Abstract | BACKGROUND/PURPOSE: METHODS: 2.6 mm diameter full-thickness osseous wounds were created bilaterally in 54 healthy Sprague-Dawley rats. Rats received daily normal saline, AG, or PTB injections respectively and were euthanized after 7 days, 14 days, or 28 days (n = 6). The wound healing pattern was assessed by micro-computed tomography, histology, histochemistry for the fiber arrangement, and the gene expression levels of AGE receptor, tumor necrosis factor-α, type I collagen, and fibronectin. RESULTS: Under the AG and PTB administration, osteogenesis was apparently promoted in the early stages of healing, but the union of the osseous wound and the fibril re-arrangement was apparently retarded. No significant difference was found in any of the micro-computed tomography parameters as compared to the control in the first 14 days, whereas the relative bone volume was significantly higher in the control at Day 28. AGE receptor and tumor necrosis factor-α were depressed in the PTB group, but only temporarily at Day 14 in the AG group. Therefore, at Day 14, type I collagen was significantly upregulated in the PTB group, and fibronectin was significantly increased in the AG group. CONCLUSION: Anti-AGE agents reduced inflammation but did not apparently facilitate osteogenesis during the osseous wound repair.
|
Authors | Sheng-Chueh Tsai, Yi-Han Jheng, Chen-Ying Wang, Yi-Wen Chen, Yu-Fang Lin, Chih-Cheng Chen, Po-Chun Chang |
Journal | Journal of the Formosan Medical Association = Taiwan yi zhi
(J Formos Med Assoc)
Vol. 114
Issue 10
Pg. 973-80
(Oct 2015)
ISSN: 0929-6646 [Print] Singapore |
PMID | 24389269
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013. Published by Elsevier B.V. |
Chemical References |
- Ager protein, rat
- Collagen Type I
- Fibronectins
- Glycation End Products, Advanced
- Guanidines
- N-phenacylthiazolium bromide
- Receptor for Advanced Glycation End Products
- Thiazoles
- Tumor Necrosis Factor-alpha
- pimagedine
|
Topics |
- Animals
- Collagen Type I
(metabolism)
- Disease Models, Animal
- Fibronectins
(metabolism)
- Glycation End Products, Advanced
(metabolism)
- Guanidines
(administration & dosage)
- Male
- Mandibular Injuries
(drug therapy)
- Rats
- Rats, Sprague-Dawley
- Receptor for Advanced Glycation End Products
(metabolism)
- Thiazoles
(administration & dosage)
- Tumor Necrosis Factor-alpha
(metabolism)
- Wound Healing
(drug effects)
- X-Ray Microtomography
|